Non-invasive chronic kidney disease risk stratification tool derived from retina-based deep learning and clinical factors

被引:11
作者
Joo, Young Su [1 ,2 ]
Rim, Tyler Hyungtaek [3 ,4 ,5 ]
Koh, Hee Byung [1 ,6 ]
Yi, Joseph [7 ]
Kim, Hyeonmin [3 ]
Lee, Geunyoung [3 ]
Kim, Young Ah [8 ]
Kang, Shin-Wook [1 ]
Kim, Sung Soo [9 ]
Park, Jung Tak [1 ]
机构
[1] Yonsei Univ, Inst Kidney Dis Res, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Yonsei Univ, Yongin Severance Hosp, Coll Med, Dept Internal Med,Div Nephrol, Yongin, South Korea
[3] Mediwhale Inc, Seoul, South Korea
[4] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore
[5] Duke NUS Med Sch, Ophthalmol & Visual Sci Acad Clin Program Eye ACP, Singapore, Singapore
[6] Catholic Kwandong Univ, Int St Marys Hosp, Dept Internal Med, Incheon, South Korea
[7] Albert Einstein Coll Med, New York, NY USA
[8] Yonsei Univ Hlth Syst, Div Digital Hlth, Seoul, South Korea
[9] Yonsei Univ, Severance Hosp, Coll Med, Inst Vis Res,Dept Ophthalmol, Seoul, South Korea
关键词
GLOMERULAR-FILTRATION-RATE; DIABETIC-NEPHROPATHY; BLOOD-PRESSURE; END-POINTS; PREDICTION; CREATININE; PHOTOGRAPHS; PROGRESSION;
D O I
10.1038/s41746-023-00860-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Despite the importance of preventing chronic kidney disease (CKD), predicting high-risk patients who require active intervention is challenging, especially in people with preserved kidney function. In this study, a predictive risk score for CKD (Reti-CKD score) was derived from a deep learning algorithm using retinal photographs. The performance of the Reti-CKD score was verified using two longitudinal cohorts of the UK Biobank and Korean Diabetic Cohort. Validation was done in people with preserved kidney function, excluding individuals with eGFR <90 mL/min/1.73 m(2) or proteinuria at baseline. In the UK Biobank, 720/30,477 (2.4%) participants had CKD events during the 10.8-year follow-up period. In the Korean Diabetic Cohort, 206/5014 (4.1%) had CKD events during the 6.1-year follow-up period. When the validation cohorts were divided into quartiles of Reti-CKD score, the hazard ratios for CKD development were 3.68 (95% Confidence Interval [CI], 2.88-4.41) in the UK Biobank and 9.36 (5.26-16.67) in the Korean Diabetic Cohort in the highest quartile compared to the lowest. The Reti-CKD score, compared to eGFR based methods, showed a superior concordance index for predicting CKD incidence, with a delta of 0.020 (95% CI, 0.011-0.029) in the UK Biobank and 0.024 (95% CI, 0.002-0.046) in the Korean Diabetic Cohort. In people with preserved kidney function, the Reti-CKD score effectively stratifies future CKD risk with greater performance than conventional eGFR-based methods.
引用
收藏
页数:7
相关论文
共 41 条
  • [1] Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
    Adler, AI
    Stevens, RJ
    Manley, SE
    Bilous, RW
    Cull, CA
    Holman, RR
    [J]. KIDNEY INTERNATIONAL, 2003, 63 (01) : 225 - 232
  • [2] A study of the natural history of diabetic kidney disease (DKD)
    Altemtam, Nagi
    Russell, Jean
    El Nahas, Meguid
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (05) : 1847 - 1854
  • [3] 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2022
    American Diabetes Association Professional Practice Committee
    [J]. DIABETES CARE, 2022, 45 : S46 - S59
  • [4] [Anonymous], 2019, Am J Kidney Dis, DOI 10.1053/j.ajkd.2019.09.002
  • [5] [Anonymous], 2013, Kidney Int Suppl (2011), V3, P63
  • [6] Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
    Bikbov, Boris
    Purcell, Carrie
    Levey, Andrew S.
    Smith, Mari
    Abdoli, Amir
    Abebe, Molla
    Adebayo, Oladimeji M.
    Afarideh, Mohsen
    Agarwal, Sanjay Kumar
    Agudelo-Botero, Marcela
    Ahmadian, Elham
    Al-Aly, Ziyad
    Alipour, Vahid
    Almasi-Hashiani, Amir
    Al-Raddadi, Rajaa M.
    Alvis-Guzman, Nelson
    Amini, Saeed
    Andrei, Tudorel
    Andrei, Catalina Liliana
    Andualem, Zewudu
    Anjomshoa, Mina
    Arabloo, Jalal
    Ashagre, Alebachew Fasil
    Asmelash, Daniel
    Ataro, Zerihun
    Atout, Maha Moh'd Wahbi
    Ayanore, Martin Amogre
    Badawi, Alaa
    Bakhtiari, Ahad
    Ballew, Shoshana H.
    Balouchi, Abbas
    Banach, Maciej
    Barquera, Simon
    Basu, Sanjay
    Bayih, Mulat Tirfie
    Bedi, Neeraj
    Bello, Aminu K.
    Bensenor, Isabela M.
    Bijani, Ali
    Boloor, Archith
    Borzi, Antonio M.
    Camera, Luis Alberto
    Carrero, Juan J.
    Carvalho, Felix
    Castro, Franz
    Catala-Lopez, Ferran
    Chang, Alex R.
    Chin, Ken Lee
    Chung, Sheng-Chia
    Cirillo, Massimo
    [J]. LANCET, 2020, 395 (10225) : 709 - 733
  • [7] Cheung K. L., 2023, AM J KIDNEY DIS
  • [8] Coca SG, 2012, ARCH INTERN MED, V172, P761, DOI 10.1001/archinternmed.2011.2230
  • [9] Recently updated global diabetic retinopathy screening guidelines: commonalities, differences, and future possibilities
    Das, Taraprasad
    Takkar, Brijesh
    Sivaprasad, Sobha
    Thanksphon, Thamarangsi
    Taylor, Hugh
    Wiedemann, Peter
    Nemeth, Janos
    Nayar, Patanjali D.
    Rani, Padmaja Kumari
    Khandekar, Rajiv
    [J]. EYE, 2021, 35 (10) : 2685 - 2698
  • [10] Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy:: Post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
    Eijkelkamp, Wouter B. A.
    Zhang, Zhongxin
    Remuzzi, Giuseppe
    Parving, Hans-Henrik
    Cooper, Mark E.
    Keane, William F.
    Shahinfar, Shahnaz
    Gleim, Gilbert W.
    Weir, Matthew R.
    Brenner, Barry M.
    de Zeeuw, Dick
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (05): : 1540 - 1546